ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report) and CI&T (NYSE:CINT – Get Free Report) are both small-cap technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, profitability and dividends.
Insider & Institutional Ownership
6.4% of ChronoScale Corporation Common Stock shares are owned by institutional investors. Comparatively, 92.4% of CI&T shares are owned by institutional investors. 6.9% of ChronoScale Corporation Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Valuation & Earnings
This table compares ChronoScale Corporation Common Stock and CI&T”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ChronoScale Corporation Common Stock | $12.80 million | 5.82 | -$11.69 million | ($5.38) | -3.89 |
| CI&T | $489.65 million | 0.98 | $40.62 million | $0.31 | 11.53 |
CI&T has higher revenue and earnings than ChronoScale Corporation Common Stock. ChronoScale Corporation Common Stock is trading at a lower price-to-earnings ratio than CI&T, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
ChronoScale Corporation Common Stock has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, CI&T has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500.
Profitability
This table compares ChronoScale Corporation Common Stock and CI&T’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ChronoScale Corporation Common Stock | -135.66% | -197.81% | -74.17% |
| CI&T | 7.90% | 13.19% | 7.32% |
Analyst Recommendations
This is a summary of recent ratings for ChronoScale Corporation Common Stock and CI&T, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ChronoScale Corporation Common Stock | 1 | 1 | 0 | 0 | 1.50 |
| CI&T | 2 | 2 | 7 | 0 | 2.45 |
ChronoScale Corporation Common Stock presently has a consensus price target of $6.00, indicating a potential downside of 71.33%. CI&T has a consensus price target of $6.41, indicating a potential upside of 79.33%. Given CI&T’s stronger consensus rating and higher probable upside, analysts clearly believe CI&T is more favorable than ChronoScale Corporation Common Stock.
Summary
CI&T beats ChronoScale Corporation Common Stock on 11 of the 14 factors compared between the two stocks.
About ChronoScale Corporation Common Stock
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
About CI&T
CI&T, Inc. provides strategy, design and software engineering services to enable digital transformation. The firm’s solutions and services include Digital Strategy, Customer-Centric Design and Top-of-the-Line Software Engineering. The company was founded by Cesar Nivaldo Gon, Bruno Guiçardi Neto and Fernando Matt Borges Martins on June 7, 2021 and is headquartered in Sao Paulo, Brazil.
Receive News & Ratings for ChronoScale Corporation Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChronoScale Corporation Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
